BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 21868456)

  • 1. Investigating mixed hyperlipidaemia.
    Viljoen A; Wierzbicki AS
    BMJ; 2011 Aug; 343():d5146. PubMed ID: 21868456
    [No Abstract]   [Full Text] [Related]  

  • 2. Metabolic syndrome and its components in men.
    Adriansjah H; Adam JM
    Acta Med Indones; 2005; 37(2):66-70. PubMed ID: 20066787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association between masked hypertension and waist circumference as an obesity-related anthropometric index for metabolic syndrome: the Ohasama study.
    Asayama K; Sato A; Ohkubo T; Mimura A; Hayashi K; Kikuya M; Yasui D; Kanno A; Hara A; Hirose T; Obara T; Metoki H; Inoue R; Hoshi H; Satoh H; Imai Y
    Hypertens Res; 2009 Jun; 32(6):438-43. PubMed ID: 19390540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of three-dimensional body scanner: observation of prevalence of metabolic syndrome.
    Lin JD; Chiou WK; Weng HF; Fang JT; Liu TH
    Clin Nutr; 2004 Dec; 23(6):1313-23. PubMed ID: 15556253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal liver function in children with metabolic syndrome from a UK-based obesity clinic.
    Wei C; Ford A; Hunt L; Crowne EC; Shield JP
    Arch Dis Child; 2011 Nov; 96(11):1003-7. PubMed ID: 21097793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic syndrome, impaired fasting glucose and obesity, as predictors of incident diabetes in 14 120 hypertensive patients of ASCOT-BPLA: comparison of their relative predictability using a novel approach.
    Gupta AK; Prieto-Merino D; Dahlöf B; Sever PS; Poulter NR;
    Diabet Med; 2011 Aug; 28(8):941-7. PubMed ID: 21749444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Epidemiological survey of prevalence of fatty liver and its risk factors in a general adult population of Shanghai].
    Fang JG; Zhu J; Li XJ; Li R; Dai F; Song XM; Chen L; Li F; Chen SY
    Zhonghua Gan Zang Bing Za Zhi; 2005 Feb; 13(2):83-8. PubMed ID: 15727689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Waist circumference and metabolic risk factors have separate and additive effects on the risk of future Type 2 diabetes in patients with vascular diseases. A cohort study.
    Wassink AM; van der Graaf Y; van Haeften TW; Spiering W; Soedamah-Muthu SS; Visseren FL;
    Diabet Med; 2011 Aug; 28(8):932-40. PubMed ID: 21749443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fatty liver index as an indicator of metabolic syndrome.
    Rogulj D; Konjevoda P; Milić M; Mladinić M; Domijan AM
    Clin Biochem; 2012 Jan; 45(1-2):68-71. PubMed ID: 22056738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic steatosis: a mediator of the metabolic syndrome. Lessons from animal models.
    den Boer M; Voshol PJ; Kuipers F; Havekes LM; Romijn JA
    Arterioscler Thromb Vasc Biol; 2004 Apr; 24(4):644-9. PubMed ID: 14715643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type II Diabetes Mellitus and impaired glucose tolerance in Yemen: prevalence, associated metabolic changes and risk factors.
    Al-Habori M; Al-Mamari M; Al-Meeri A
    Diabetes Res Clin Pract; 2004 Sep; 65(3):275-81. PubMed ID: 15331208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosing metabolic syndrome in type 2 diabetes: does it matter?
    Song SH; Hardisty CA
    QJM; 2008 Jun; 101(6):487-91. PubMed ID: 18353792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A high risk score for coronary heart disease is associated with the metabolic syndrome in 40-year-old men and women.
    Tonstad S; Hjermann I
    J Cardiovasc Risk; 2003 Apr; 10(2):129-35. PubMed ID: 12668910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Role of abdominal obesity in pathogenesis of insulin resistance syndrome].
    Almazov VA; Blagosklonnaia IaV; Shliakhto EV; Krasil'nikova EI
    Ter Arkh; 1999; 71(10):18-22. PubMed ID: 10612167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Non-alcoholic fatty liver].
    Bhala N; Usherwood T; George J
    Praxis (Bern 1994); 2010 Feb; 99(3):187-9. PubMed ID: 20127639
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of metabolic syndrome.
    Wagh A; Stone NJ
    Expert Rev Cardiovasc Ther; 2004 Mar; 2(2):213-28. PubMed ID: 15151470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obesity; epiphenomenon or cause of metabolic syndrome?
    Lois K; Young J; Kumar S
    Int J Clin Pract; 2008 Jun; 62(6):932-8. PubMed ID: 18479286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Undetected type 2 diabetes in older adults.
    Dankner R; Geulayov G; Olmer L; Kaplan G
    Age Ageing; 2009 Jan; 38(1):56-62. PubMed ID: 19008303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycaemic variability using continuous glucose monitoring and endothelial function in the metabolic syndrome and in Type 2 diabetes.
    Buscemi S; Re A; Batsis JA; Arnone M; Mattina A; Cerasola G; Verga S
    Diabet Med; 2010 Aug; 27(8):872-8. PubMed ID: 20653743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Metabolic syndrome].
    Hanefeld M; Scriba P
    Internist (Berl); 1996 Jul; 37(7):679-80. PubMed ID: 8766260
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.